Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-15 · accession 0001673232-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-03-17 | 2026-03-15 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | — | +33.4K | 33.8K | +9,022% | — |
| DMI | 2026-03-17 | 2026-03-15 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | F - Tax | $536.12 | -14.7K | 25.9K | -36% | -$7.88M |
| DMI | 2026-03-17 | 2026-03-15 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $0.00 | -33.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-15 | M | A | 17,790 | — | 17,790 | I by Trust | — | — | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F2) Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 2 | Common | Common Stock | 2026-03-15 | F | D | 6,869 | $536.12 | 19,046 | I by Trust | — | — | (F3) Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. (F2) Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 3 | Common | Common Stock | 2026-03-15 | F | D | 7,837 | $536.12 | 25,915 | I by Trust | — | — | (F3) Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. (F2) Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 4 | Common | Common Stock | 2026-03-15 | M | A | 15,592 | — | 33,752 | I by Trust | — | — | (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F2) Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 5 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 17,790 | $0.00 | 0 | I by Trust | — · — to — | 17,790 Common Stock | (F2) Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F5) Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023. |
| 6 | Derivative | Restricted Stock Units | 2026-03-15 | M | D | 15,592 | $0.00 | 0 | I by Trust | — · — to — | 15,592 Common Stock | (F2) Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. (F1) Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. (F5) Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023. |